Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACRE in Ulcerative Colitis
NCT04000139Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Apr 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ulcerative colitis (UC) comparing ACRE with Placebo (2 arms). Primary endpoint: Clinical response at 8 weeks. Started Apr 2019; status: completed.
02
Drugs
anthocyanin-rich extract
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04000139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04000139.